eMed vs Solv Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $200M Series A (Mar 2026) at $2B+ valuation led by AON Consulting. 91%+ medication adherence. GLP-1 benefits platform for employers. Linda Yaccarino CEO.
About
eMed is a GLP-1 and metabolic health benefits platform built specifically for employer-sponsored health plans, the fastest-growing category in US workplace benefits. The company raised $200 million in Series A financing in March 2026 at a $2 billion+ valuation led by AON Consulting, with backing from Linda Yaccarino (former Twitter/X CEO, now eMed CEO) and Tom Brady. Claiming 91%+ medication adherence rates, eMed positions itself as the most effective GLP-1 benefits program available to employers.
Solv Health is a same-day appointment booking platform for urgent care, primary care, and telehealth, offering patients transparent wait times and insurance-aware scheduling.
About
Solv Health operates a consumer-facing booking platform that aggregates same-day availability from urgent care centers, primary care practices, and telehealth providers — giving patients the ability to find and book immediate care without calling multiple clinics or waiting in walk-in lines. The platform displays real-time wait times, insurance acceptance, and directions, making the experience of finding immediate care as simple as booking a restaurant reservation.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.